Navigation Links
Pancreatic cancers use fructose, common in the Western diet, to fuel their growth
Date:8/3/2010

e malignant cells in Petri dishes. They then added glucose to one set of cells and fructose to another. Using mass spectrometry, they were able to follow the carbon-labeled sugars in the cells to determine what exactly they were being used for and how.

Heaney found that the pancreatic cancer cells could easily distinguish between glucose and fructose even though they are very similar structurally, and contrary to conventional wisdom, the cancer cells metabolized the sugars in very different ways. In the case of fructose, the pancreatic cancer cells used the sugar in the transketolase-driven non-oxidative pentose phosphate pathway to generate nucleic acids, the building blocks of RNA and DNA, which the cancer cells need to divide and proliferate.

"Traditionally, glucose and fructose have been considered as interchangeable monosaccharide substrates that are similarly metabolized, and little attention has been given to sugars other than glucose," the study states. "However, fructose intake has increased dramatically in recent decades and cellular uptake of glucose and fructose uses distinct transporters These findings show that cancer cells can readily metabolize fructose to increase proliferation. They have major significance for cancer patients, given dietary refined fructose consumption."

As in anti-smoking campaigns, a federal effort should be launched to reduce refined fructose intake, Heaney said.

"I think this paper has a lot of public health implications," Heaney said. "Hopefully, at the federal level there will be some effort to step back on the amount of HFCS in our diets."

Heaney said that while this study was done in pancreatic cancer, these finding may not be unique to that cancer type.

Going forward, Heaney and his team are exploring whether it's possible to block the uptake of fructose in the cancer cells with a small molecule, taking away one of the fuels they need to grow. The work is being done i
'/>"/>

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. TGen-Asuragen partner to advance pancreatic cancer research
2. Predicting prognosis and treatment response in a subset of pancreatic cancer patients
3. Soft drink consumption may increase risk of pancreatic cancer
4. Oral COTI-2 is effective in a second animal model of human pancreatic cancer
5. Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant awarded to Johns Hopkins Early Career investigator
6. ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER
7. Blood-flow metabolism mismatch predicts pancreatic tumor aggressiveness
8. Newly discovered epidermal growth factor receptor active in human pancreatic cancers
9. Device protects transplanted pancreatic cells from the immune system
10. Compendium of pancreatic cancer biomarkers established as strategic approach to early-detection
11. HIV-1 protease inhibitor induced oxidative stress in pancreatic B-cells: thymoquinone protection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... lab. At Brandeis University, sophisticated computational models and ... understand the complex interplay between genomic data, virus ... "shell" critical for replication. , ... finding will help researchers alter virus assembly, leaving ... Perlmutter, first author of the scientific paper describing ...
(Date:6/18/2013)... has awarded $12.7 million to match nine academic ... compounds to explore new treatments for patients in ... dystrophy and schizophrenia. The collaborative pilot initiative, called ... led by the National Center for Advancing Translational ... Fund. , The process of developing a new ...
(Date:6/18/2013)... The herbal extract of a yellow-flowered mountain plant ... the lifespan of fruit fly populations by an average ... But it,s how Rhodiola rosea , ... the attention of study leaders Mahtab Jafari and Sam ... a manner completely unrelated to dietary restriction and affects ...
Breaking Biology News(10 mins):Computer modeling technique goes viral at Brandeis 2NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4Herbal extract boosts fruit fly lifespan by nearly 25 percent, UCI study finds 2
... for attaching a large protective polymer molecule to a ... at Duke University developed the new approach and demonstrated ... combinations, known as conjugates, remained in circulation significantly longer ... are encouraged that their findings represent a new strategy ...
... Ben-Gurion University of the Negev are developing technology to scale ... desalination by reverse osmosis to be used in a Jordanian ... Gilron of the Zuckerberg Institute for Water Research (ZIWR) and ... developed a method of exploiting the finite kinetics of membrane ...
... The 2009 American Society for Microbiology (ASM) ICAAC ... Assistant Professor, Imperial College London. Sponsored by the ... excellence in microbiology and infectious diseases. Dr. Grndling,s ... S, sits in the membrane and how S monomers ...
Cached Biology News:Novel polymer could improve protein-based drugs 2Novel polymer could improve protein-based drugs 3
(Date:6/18/2013)... DuPont welcomes 48 of the nation’s ... National AgriScience Teachers Ambassador Academy this week (NATAA) at ... , The NATAA “Ag Academy” is a ... special project of the National FFA Foundation ... . The highly recommended agriscience teachers, who are ...
(Date:6/18/2013)... June 18, 2013 ... research firm, announces the initiation of full ... biopharmaceutical company developing and marketing products for ...      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... examining the investment merits of BioAlliance Pharma, ...
(Date:6/18/2013)... This webinar will examine the history ... and review the basic FDA regulations and guiding ... these principles through real world case studies and ... on FDA regulations and guidance related to prescription ... traditional and newer forms of promotional materials for ...
(Date:6/18/2013)... 2013 Research ... announced the addition of the ... Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], ... (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) - ... their offering.      (Logo: ...
Breaking Biology Technology:DuPont Sponsors National AgriScience Ambassador Academy 2DuPont Sponsors National AgriScience Ambassador Academy 3Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 2North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 3
... Syndax Pharmaceuticals, Inc ., a late-stage epigenetics oncology company, ... upcoming fall conferences: BIO Investor Forum , ... 9th International Discovery on Target , Panel Discussion: HDACi and Their ... Lazard Annual Healthcare Conference , New York, NY, November ...
... Oct. 24, 2011 Modern Plastics, one of the ... medical-grade plastics, has become ISO 13485-2003 certified for the ... and Resin. "This is an extraordinary ... to service and quality," said Bing J. Carbone, President ...
... 2011 Silence Therapeutics plc (AIM: ... company, today announced that it has entered into ... biopharmaceutical company pioneering microRNA-based therapeutics for cancer, to ... and DBTC delivery systems for Mirna,s novel microRNAs. ...
Cached Biology Technology:Syndax Pharmaceuticals to Present at Upcoming Fall Conferences 2Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics 2Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics 3Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics 4Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics 5Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics 6
iEMS Thermal Microplate Holder...
...
Improve inventory management with stainless steel red cell canisters; ensure product safety with CO2 or LN2 backup systems. A complete solution for your blood banking needs....
... oligonucleotides: PTOs are internucleotide modifications, ... backbone is replaced by a sulphur atom. ... degradation. PTOs are available as ... Oligonucleotides with thio-caps ...
Biology Products: